# Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

> **NCT00992017** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 130 (actual)

## Conditions studied

- HIV Infections
- H1N1 Influenza Virus

## Interventions

- **BIOLOGICAL:** Influenza A (H1N1) monovalent vaccine

## Key facts

- **NCT ID:** NCT00992017
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2021-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00992017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00992017, "Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00992017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*